Petra Sansom is head of Alliance Management at Beam Therapeutics, a clinical stage biotechnology company focused on precision genetic medicines with a platform of gene editing technologies anchored by base editing. Prior to her current role, she held leadership roles including head of Alliance Management at Voyager Therapeutics, a gene therapy company focused on neurological diseases, and Genzyme Head of Alliance Management, with responsibility for alliance management for the Sanofi Genyzme division collaborations focused on rare genetic diseases. Previously, she was a Global Alliance Director at Hoffmann-La Roche where she was responsible for alliance management of global research, development, and commercial alliances in several therapeutic areas. Petra has over 20 years of experience managing alliances and leading transactional and strategic initiatives. She has a JD from Fordham Law School in New York City and a Ph.D. in Organic Chemistry from the University of Texas at Austin.